Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication - Walden, Lucas M.; Brandl, Eva J.; Tiwari, Arun K.; Cheema, Sheraz; Freeman, Natalie; Braganza, Nicole; Kennedy, James L.; Müller, Daniel J. (Psychiatry research, 2019)
Keywords: Adult; Alleles; Antidepressive Agents - adverse effects; Antidepressive Agents - therapeutic use; Antipsychotic Agents - adverse effects; Antipsychotic Agents - therapeutic use; Clinical; Cytochrome P-450 CYP2C19 - genetics; Cytochrome P-450 CYP2D6 - genetics; Depressive Disorder - drug therapy; Drug-Related Side Effects and Adverse Reactions - genetics; Female; Genetic Testing; Genetics; Genotype; Humans; Male; Middle Aged; Personalized medicine; Pharmacogenetics; Psychiatric medication; Psychotic Disorders - drug therapy; Treatment Outcome; Psychiatric medication; Clinical; Genetics; Pharmacogenetics; Personalized medicine